CCI clears Torrent Pharma’s acquisition of JB Chemicals
ECONOMY & POLICY

CCI clears Torrent Pharma’s acquisition of JB Chemicals

The Competition Commission of India (CCI) has approved the proposed acquisition of J. B. Chemicals & Pharmaceuticals Limited by Torrent Pharmaceuticals Limited, subject to voluntary modifications offered by the parties.

The transaction involves Torrent Pharmaceuticals Limited (the acquirer) purchasing shareholding in J. B. Chemicals & Pharmaceuticals Limited (the target), followed by the amalgamation of the target company with the acquirer. Together, the two entities are referred to as the “parties”.

Torrent Pharmaceuticals, the flagship company of the Torrent Group, is engaged in the manufacture and sale of pharmaceutical formulations across multiple therapeutic segments.

J. B. Chemicals & Pharmaceuticals Limited operates in the manufacturing and marketing of a wide range of finished dosage formulations (FDFs) and active pharmaceutical ingredients (APIs). The company also provides Contract Development and Manufacturing Organisation (CDMO) services.

The CCI’s approval is conditional on the compliance of voluntary modifications proposed by both parties to address competition concerns.

A detailed order from the Commission will be issued in due course.

The Competition Commission of India (CCI) has approved the proposed acquisition of J. B. Chemicals & Pharmaceuticals Limited by Torrent Pharmaceuticals Limited, subject to voluntary modifications offered by the parties. The transaction involves Torrent Pharmaceuticals Limited (the acquirer) purchasing shareholding in J. B. Chemicals & Pharmaceuticals Limited (the target), followed by the amalgamation of the target company with the acquirer. Together, the two entities are referred to as the “parties”. Torrent Pharmaceuticals, the flagship company of the Torrent Group, is engaged in the manufacture and sale of pharmaceutical formulations across multiple therapeutic segments. J. B. Chemicals & Pharmaceuticals Limited operates in the manufacturing and marketing of a wide range of finished dosage formulations (FDFs) and active pharmaceutical ingredients (APIs). The company also provides Contract Development and Manufacturing Organisation (CDMO) services. The CCI’s approval is conditional on the compliance of voluntary modifications proposed by both parties to address competition concerns. A detailed order from the Commission will be issued in due course.

Next Story
Infrastructure Urban

Panasonic Showcases Connected Display Solutions

Panasonic Life Solutions India showcased its integrated display, projection, broadcast and communication technologies at Panasonic Tech Summit 2026 in New Delhi. Hosted through its System Solutions Division, the two-day event highlighted connected technology solutions for education, healthcare, retail, transportation, corporate offices and entertainment.The summit, themed ‘Turning Technology into Value’, featured experience-led zones covering QSR, retail, transit, corporate offices, healthcare, education, security, projection, home theatre and professional displays. Panasonic also introduc..

Next Story
Infrastructure Transport

Kapsch to Deliver India’s First C-ITS Project

"Kapsch TrafficCom will deliver India’s first Cooperative Intelligent Transport Systems project on a key expressway near New Delhi. The project will be implemented with Superwave Communication And Infrasolution Limited to demonstrate how connected mobility can improve road safety and traffic efficiency.The pilot will use real-time connectivity and AI-enabled situational awareness to support road users, especially in high-risk areas such as temporary work zones. Drivers will receive alerts on roadworks, maintenance vehicles, hazardous locations, traffic queues and temporary virtual signage di..

Next Story
Infrastructure Urban

Eurobond Net Profit Rises 44 Per Cent

Euro Panel Products, the parent company of Eurobond, reported a 44.13 per cent year-on-year rise in net profit for FY25–26. The company’s revenue from operations grew 18.91 per cent to Rs 503.20 crore, compared to Rs 423.18 crore in the previous financial year.The company’s full-year EBITDA stood at Rs 56.67 crore, marking a 31.82 per cent increase. Profit after tax rose to Rs 26.56 crore, while net worth increased 20.15 per cent to Rs 160.07 crore. Earnings per share for the year stood at Rs 10.84.Divyam Rajesh Shah, Whole Time Director and CFO, Euro Panel Products, said the company’s..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

-->